Stephen Wargacki - 10 May 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Science Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
10 May 2024
Net transactions value
$0
Form type
4
Filing time
13 May 2024, 13:40:32 UTC
Previous filing
02 Oct 2024
Next filing
11 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Award $0 +10,000 +3.9% $0.000000 267,963 10 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.